HCPLive: Advanced Brain Aging Observed in Older Type 1 Diabetes Patients Compared to Those Without
June 7, 2023
Mohamad Habes, PhD, Glenn Biggs Institute/Radiology, was quoted in this article. Read More
MedPage Today: Study Suggests Increase in Brain Aging in Those With Type 1 Diabetes
June 2, 2023
Mohamad Habes, PhD, Radiology, and his colleagues, were quoted in this article. Read More
Yahoo! Finance: FDA green-lights bionic pancreas studied at UT Health Science Center San Antonio, University Health
May 31, 2023
Jane Lynch, MD, and Rabab Jafri, MD, both of the Department of Pediatrics, Division of Pediatric Endocrinology & Diabetes, were quoted in this story. Read More
FDA green-lights bionic pancreas studied at UT Health Science Center, University Health
May 25, 2023
While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the U.S. Food and Drug Administration, will relieve youth and their parents of constant worries over estimating insulin doses and carb intake from food.
Diabetes, obesity drug studied for effect on Alzheimer’s
May 25, 2023
From social media to ads featuring an earworm jingle, it’s hard to escape hearing about Ozempic. Hailed for its game-changing effect on diabetes and obesity, semaglutide, the generic medication sold under the brand name Ozempic, is now being studied for its effectiveness on another deadly disease — Alzheimer’s. The Glenn Biggs Institute for Alzheimer’s and […]
FDA green-lights bionic pancreas studied at UT Health Science Center, University Health
May 25, 2023
Artificial intelligence insulin delivery and glucose monitoring system cleared for age 6 and older Contact: Will Sansom, UT Health Science Center, 210-567-2579, sansom@uthscsa.edu University Health communications, 210-358-2335 SAN ANTONIO (May 25, 2023) — While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the […]
